Spyre Therapeutics, Inc. (SYRE)

USD 23.16

(-8.31%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 341.85 Million 71.14 Million 109.92 Million 161.61 Million 83.18 Million 77.73 Million
Total Current Assets 341.52 Million 62.25 Million 98.89 Million 149.78 Million 74.5 Million 76.67 Million
Cash And Short Term Investments 339.27 Million 55.71 Million 93.12 Million 146.27 Million 71.94 Million 74.51 Million
Cash and Cash Equivalents 188.89 Million 34.86 Million 15.14 Million 90.09 Million 19.25 Million 22.46 Million
Short Term Investments 150.38 Million 20.84 Million 77.98 Million 56.17 Million 52.69 Million 52.05 Million
Net Receivables - 375 Thousand 815 Thousand - - 300 Thousand
Inventory - - - - - -
Other Current Assets 2.25 Million 6.17 Million 4.94 Million 3.51 Million 2.55 Million 1.85 Million
Total Non-Current Assets 331 Thousand 8.88 Million 11.03 Million 11.82 Million 8.67 Million 1.06 Million
Net PPE - 6.65 Million 8.35 Million 9.87 Million 7.16 Million 1.01 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 322 Thousand 1.55 Million 1.83 Million 1.84 Million 1.5 Million -
Tax Assets - - - - - -
Other Non Current Assets 9000.00 683 Thousand 842 Thousand 115 Thousand 11 Thousand 49.99 Thousand
Other Assets - - - - - 1.00
Total Liabilities 157.84 Million 20.83 Million 25.98 Million 21.78 Million 23.1 Million 10.31 Million
Total Current Liabilities 31.97 Million 14.65 Million 20.14 Million 16.44 Million 18.35 Million 10.23 Million
Account Payables 896 Thousand 677 Thousand 3.31 Million 2.25 Million 3.15 Million 663 Thousand
Tax Payables - - - - - -
Short Term Debt - 625 Thousand 436 Thousand 319 Thousand 379 Thousand -
Deferred Revenue - 517 Thousand 2.35 Million 13.4 Million - -
Other Current Liabilities 31.08 Million 12.83 Million 14.03 Million 464 Thousand 14.82 Million 9.57 Million
Total Non Current Liabilities 125.86 Million 6.18 Million 5.84 Million 5.34 Million 4.74 Million 71.99 Thousand
Long-Term Debt 84.55 Million 4 Million 4.62 Million 5.12 Million - -
Deferred Revenue Non Current - 2.17 Million 1.21 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 41.31 Million - - 214 Thousand 4.74 Million 71.99 Thousand
Other Liabilities - - - - 1.00 1.00
Total Equity 184.01 Million 50.3 Million 83.94 Million 139.83 Million 60.08 Million 67.42 Million
Stock Holders Equity 184.01 Million 50.3 Million 83.94 Million 139.83 Million 60.08 Million 67.42 Million
Common Stock 10 Thousand 6000.00 5000.00 5000.00 3000.00 2000.00
Retained Earnings -764.41 Million -425.62 Million -341.8 Million -276 Million -195.11 Million -116.86 Million
Accumulated other comprehensive income 302 Thousand -48 Thousand -20 Thousand 11 Thousand 51 Thousand -27 Thousand
Common Stock Equity 184.01 Million 50.3 Million 83.94 Million 139.83 Million 60.08 Million 67.42 Million
Capital Lease Obligation - 4.62 Million 5.06 Million 5.44 Million 4.74 Million -
Total Investments 150.38 Million 20.84 Million 77.98 Million 56.17 Million 54.19 Million 52.05 Million
Total Debt 84.55 Million 4.62 Million 5.06 Million 5.44 Million 5.12 Million -
Net Debt -104.33 Million -30.23 Million -10.08 Million -84.64 Million -14.13 Million -22.46 Million

Balance Sheet Charts